اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدExploration of heterogeneous treatment effects via concave fusion
223
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
Understanding treatment heterogeneity is essential to the development of precision medicine, which seeks to tailor medical treatments to subgroups of patients with similar characteristics. One of the challenges to achieve this goal is that we usually do not have a priori knowledge of the grouping information of patients with respect to treatment. To address this problem, we consider a heterogeneous regression model by assuming that the coefficient for treatment variables are subject-dependent and belong to different subgroups with unknown grouping information. We develop a concave fusion penalized method for automatically estimating the grouping structure and the subgroup-specific treatment effects, and derive an alternating direction method of multipliers algorithm for its implementation. We also study the theoretical properties of the proposed method and show that under suitable conditions there exists a local minimizer that equals the oracle least squares estimator with a priori knowledge of the true grouping information with high probability. This provides theoretical support for making statistical inference about the subgroup-specific treatment effects based on the proposed method. We evaluate the performance of the proposed method by simulation studies and illustrate its application by analyzing the data from the AIDS Clinical Trials Group Study.
قيم البحث
اقرأ أيضاً
Understanding treatment effect heterogeneity in observational studies is of great practical importance to many scientific fields because the same treatment may affect different individuals differently. Quantile regression provides a natural framework
for modeling such heterogeneity. In this paper, we propose a new method for inference on heterogeneous quantile treatment effects that incorporates high-dimensional covariates. Our estimator combines a debiased $ell_1$-penalized regression adjustment with a quantile-specific covariate balancing scheme. We present a comprehensive study of the theoretical properties of this estimator, including weak convergence of the heterogeneous quantile treatment effect process to the sum of two independent, centered Gaussian processes. We illustrate the finite-sample performance of our approach through Monte Carlo experiments and an empirical example, dealing with the differential effect of mothers education on infant birth weights.
In the recent literature on estimating heterogeneous treatment effects, each proposed method makes its own set of restrictive assumptions about the interventions effects and which subpopulations to explicitly estimate. Moreover, the majority of the l
iterature provides no mechanism to identify which subpopulations are the most affected--beyond manual inspection--and provides little guarantee on the correctness of the identified subpopulations. Therefore, we propose Treatment Effect Subset Scan (TESS), a new method for discovering which subpopulation in a randomized experiment is most significantly affected by a treatment. We frame this challenge as a pattern detection problem where we efficiently maximize a nonparametric scan statistic over subpopulations. Furthermore, we identify the subpopulation which experiences the largest distributional change as a result of the intervention, while making minimal assumptions about the interventions effects or the underlying data generating process. In addition to the algorithm, we demonstrate that the asymptotic Type I and II error can be controlled, and provide sufficient conditions for detection consistency--i.e., exact identification of the affected subpopulation. Finally, we validate the efficacy of the method by discovering heterogeneous treatment effects in simulations and in real-world data from a well-known program evaluation study.
Forest-based methods have recently gained in popularity for non-parametric treatment effect estimation. Building on this line of work, we introduce causal survival forests, which can be used to estimate heterogeneous treatment effects in a survival a
nd observational setting where outcomes may be right-censored. Our approach relies on orthogonal estimating equations to robustly adjust for both censoring and selection effects. In our experiments, we find our approach to perform well relative to a number of baselines.
Estimation of heterogeneous treatment effects is an essential component of precision medicine. Model and algorithm-based methods have been developed within the causal inference framework to achieve valid estimation and inference. Existing methods suc
h as the A-learner, R-learner, modified covariates method (with and without efficiency augmentation), inverse propensity score weighting, and augmented inverse propensity score weighting have been proposed mostly under the square error loss function. The performance of these methods in the presence of data irregularity and high dimensionality, such as that encountered in electronic health record (EHR) data analysis, has been less studied. In this research, we describe a general formulation that unifies many of the existing learners through a common score function. The new formulation allows the incorporation of least absolute deviation (LAD) regression and dimension reduction techniques to counter the challenges in EHR data analysis. We show that under a set of mild regularity conditions, the resultant estimator has an asymptotic normal distribution. Within this framework, we proposed two specific estimators for EHR analysis based on weighted LAD with penalties for sparsity and smoothness simultaneously. Our simulation studies show that the proposed methods are more robust to outliers under various circumstances. We use these methods to assess the blood pressure-lowering effects of two commonly used antihypertensive therapies.
For many kinds of interventions, such as a new advertisement, marketing intervention, or feature recommendation, it is important to target a specific subset of people for maximizing its benefits at minimum cost or potential harm. However, a key chall
enge is that no data is available about the effect of such a prospective intervention since it has not been deployed yet. In this work, we propose a split-treatment analysis that ranks the individuals most likely to be positively affected by a prospective intervention using past observational data. Unlike standard causal inference methods, the split-treatment method does not need any observations of the target treatments themselves. Instead it relies on observations of a proxy treatment that is caused by the target treatment. Under reasonable assumptions, we show that the ranking of heterogeneous causal effect based on the proxy treatment is the same as the ranking based on the target treatments effect. In the absence of any interventional data for cross-validation, Split-Treatment uses sensitivity analyses for unobserved confounding to select model parameters. We apply Split-Treatment to both a simulated data and a large-scale, real-world targeting task and validate our discovered rankings via a randomized experiment for the latter.
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
